Home Precision Medicine Business

Business

Latest
Drawing Blood
News Briefs

Lloyd Sanders Named New CEO of Epic Sciences

Killer T-lymphocyte attacking a cancer cell
Business

10 Leading Immuno-Oncology Startups

Source: Melitios Verros/Getty Images
Business

Mammoth Competition: Feng Zhang, Partners Launch CRISPR Dx Company

Source: Raycat/Getty Images
Business

Viome, Helomics Partner on Personalized Ovarian Cancer Treatments

Ambry Genetics and My Gene Counsel said they will partner to offer medical-grade testing designed to confirm results of direct-to-consumer (DTC) genetic tests
Business

Ambry and My Gene Counsel Team Up on Tests to Confirm...

The UK government said it will spend £45 million ($59.7 million) toward projects aimed at increasing the computing
Business

UK Commits £45M Toward Capacity Expansion at EMBL-EBI

Myriad Genetics has received a final local coverage determination for its myPath Melanoma test from the Medicare Administrative Contractor Palmetto GBA MolDx. [Myriad Genetics]
Business

Myriad Genetics Gets Medicare Coverage for myPath Melanoma Test

Lucence Diagnostics will partner with a Stanford University researcher to develop AI algorithms designed to improve the diagnosis and treatment of liver cancer. [Lucence Diagnostics]
Business

Lucence, Stanford Researcher to Develop AI Algorithms for Liver Cancer Treatment

BGI Genomics plans to commercialize Natera’s Signatera molecular residual disease (MRD) test in China
Business

BGI Genomics to Commercialize Natera’s Signatera Assay in China

Biocartis will partner with Bristol-Myers Squibb (BMS) to develop a companion diagnostic for the pharma giant’s immuno-oncology therapies based on the Belgian molecular diagnostics developer’s Idylla MSI test. [Biocartis]
Business

Biocartis, BMS to Partner on CDx for mCRC Immunotherapy Combination

Load more

New Products

View More
Load more
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up